I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Complete pathological remission and tertiary lymphoid struc..:
Ying Liu
;
Lei Xiong
;
Yue Chen
...
https://www.tandfonline.com/doi/10.1080/21645515.2023.2285902. , 2023
Link:
https://doi.org/10.1080/21645515.2023.2285902
RT Journal T1
Complete pathological remission and tertiary lymphoid structures are associated with the efficacy of resectable NSCLC receiving neoadjuvant chemoimmunotherapy: A double-center retrospective study
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:5b2c8f3154bd46d196e22dc4e1642aa8&Exemplar=1&LAN=DE A1 Ying Liu A1 Lei Xiong A1 Yue Chen A1 Ruoxue Cai A1 Xinyu Xu A1 Tian Wang A1 Yiyu Guo A1 Luxi Ruan A1 Ying Fang A1 Quanan Zhang A1 Bo Shen A1 Jinjun Ye A1 Guoren Zhou PB Taylor & Francis Group YR 2023 K1 Tertiary lymphoid structure K1 neoadjuvant chemoimmunotherapy K1 complete pathological remission K1 non-small cell lung cancer K1 prognosis K1 Immunologic diseases. Allergy K1 RC581-607 K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.tandfonline.com/doi/10.1080/21645515.2023.2285902 LK http://dx.doi.org/https://doi.org/10.1080/21645515.2023.2285902 DO https://doi.org/10.1080/21645515.2023.2285902 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)